Bracco Diagnostics of Princeton, NJ, has been awarded a contract by group purchasing organization Amerinet.
Under terms of the agreement, Bracco's injectable contrast media products will be made available to Amerinet members via a single contract through 2008, the company said.
The contract includes Isovue (iopamidol injection); MultiHance (gadobenate dimeglumine) injection, 529 mg/mL; ProHance (gadoteridol) injection, 279.3 mg/mL; and Bracco's ionic product line.
By AuntMinnie.com staff writers
January 26, 2006
Related Reading
Bracco to sell Esaote, January 23, 2006
Esaote rolls out Picus-Just 4D ultrasound, November 11, 2005
Bracco, Toshiba partner in 64-slice CTA trial, July 13, 2005
FDA OKs expanded use for Kinevac, June 1, 2005
Consorta selects Bracco, May 26, 2005
Copyright © 2006 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)